Natasa Zamurovic Ribrioux

Company: Novartis

Job title: Strategy & Portfolio Director-Preclinical Safety/ Translational Medicine

Bio:

Understanding preclinical species selection to accurately assess pharmacology and safety of targeted protein degraders

For more information on this session, please download the full event guide.

Day: Pre-Conference Workshop Day